Figure 1

Phenotypic profile of circulating CLA⁺ NK cells in adult AD (ex vivo). (a) Representative gating strategy to analyze circulating CLA⁺ NK cells; (b) The frequency of CD56^bright and CD56^dim NK cells subsets (CD56^brightCD16⁻ and CD56^dimCD16⁺); (c) CLA expression on circulant CD56⁺ NK cells. HC (n = 10), mild/moderate AD (n = 5) and severe AD (n = 6). Data was plotted as a median with an interquartile range. *p < 0.05; **p < 0.01 and ***p < 0.001.